Article

Vitamin D Deficiency Is Significantly More Common in People with Noninfectious Uveitis

Presented at the American Academy of Ophthalmology 2016 Annual Meeting (AAO 2016), one study looked at how vitamin D is involved in the world of uveitis.

ophthalmology, uveitis, noninfectious uveitis, pharmacy, vitamin D, American Academy of Ophthalmology 2016 Annual Meeting, AAO 2016

Researchers have long stressed the importance of sufficient vitamin D levels. It’s been shown to improve bone turnover markers in postmenopausal women and historical exposure is tied to multiple sclerosis outcomes. Presented at the American Academy of Ophthalmology 2016 Annual Meeting (AAO 2016), one study looked at how vitamin D is involved in the world of uveitis.

There are two types of uveitis — infectious and noninfectious. The first is brought about from a virus or bacteria in the eye and the second can develop from another injury or disease in the body – such as multiple sclerosis, psoriasis, and the acquired immunodeficiency virus (AIDS). In this recent study, Samaneh Dayoudi, MD, of the Amirkabir University of Technology, and colleagues aimed to find if there was a relationship between noninfectious uveitis and plasma vitamin D levels.

The team looked at 100 people with noninfectious uveitis and compared them to 100 healthy controls. Their total 25 (OH) vitamin D plasma levels were recorded, as well as other clinical and demographic information. Hypovitaminosis, or vitamin D deficiency, showed to be associated with noninfectious uveitis.

“Hypovitaminosis D was significantly more common in uveitis patients (odds ratio (OR): 2.53),” the report said. “It remained significant after adjusting for age, gender, race, the month of the blood draw, and vitamin D supplement use (OR: 2.94).”

Multivariate regression models confirmed that vitamin D deficiency was associated with an increased risk of noninfectious uveitis.

Related Coverage:

Flying Eye Hospital Brings Invaluable Resources for Patients Worldwide

Incidence of Syphilis Has Been Increasing, and Uveitis May Be Its First Sign

Adalimumab: Efficacy and Adverse Effects for Patients with Active Noninfectious Uveitis

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.